Mota Ventures Enters into Binding Term Sheet to Acquire 110,000 Square Foot European Pharmaceutical Manufacturer of Natural Psilocybin Products
Mota Ventures Reports Record Revenues for Month of April of CDN$3,818,000 From CBD Products, an Increase of 39 Percent From April 2019
Mota Ventures to Replicate Successful U.S. Business Model for European Expansion of CBD Products, Immune Product Line and CBD Hand Sanitizer
Mota Ventures Announces Record Number of Subscriptions Year-To-Date in March and Over 6,000 New Customers in April
Cannabis Big News: Mota Ventures Launches Immune Support CBD Line, BevCanna Signs LOI with California Beverage Brand Calexo
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
